logo image
search icon
Next-Generation Contraceptives Market

Next-Generation Contraceptives Market Size, Share & Trends Analysis Distribution by Gender (Male, Female), End User (Hospital Pharmacies, Retail Pharmacies, Online Channels), Offering (Drugs, Devices), and Segment Forecasts, 2024-2031

Report ID : 2534 | Published : 2024-06-19 | Pages: 180 | Format: PDF/EXCEL

Next-Generation Contraceptives Market Size is predicted to exhibit an 8.2% CAGR during the forecast period for 2024-2031.

Next-Generation Contraceptives Market info

Next-generation contraceptives represent a promising frontier in reproductive health, containing a diverse array of innovative methods designed to prevent pregnancy effectively. For men, ongoing research includes the development of hormonal and non-hormonal options such as a pill that inhibits fertility by blocking vitamin A access, an injectable solution that temporarily obstructs sperm transport, and a topical gel for daily application to induce temporary infertility.

These next-generation contraceptives are significant beyond their innovative features. By providing more effective and reversible methods, they hold the potential to meet the unmet need for contraception globally, estimated to affect approximately 200 million women. Enhanced accessibility to these advanced methods could lead to a marked reduction in unintended pregnancies and contribute significantly to the prevention of sexually transmitted infections (STIs), thereby promoting better reproductive health outcomes worldwide. These advancements represent a crucial step forward in empowering individuals with greater control over their reproductive choices and health. The rising prevalence of sexually transmitted infections (STIs) is a significant driving factor for the demand for contraception devices, particularly in regions like Australia and New Zealand.

Competitive Landscape

Some of the Key Players in Next-Generation Contraceptives Market:

  • AbbVie
  • Bayer Corporation
  • Cooper Surgical, Inc.
  • Church & Dwight Co, Inc.
  • Merck & Co Inc.
  • Pfizer
  • Reckitt Benckiser Group Plc
  • Teva Pharmaceuticals Industries Ltd.
  • The Female Health Company/Veru Inc.
  • Afaxys, Inc
  • Aditxt
  • Daré Bioscience, Inc
  • TherapeuticsMD, Inc                    

Market Segmentation:

The Next-Generation Contraceptives market is segmented by gender, end user, and offering. Gender segment includes male and female. By end user is categorized into hospital pharmacies, retail pharmacies, online channels, others. By offering the market is categorized into drugs, devices.

Online Channels is Expected to Drive the Next-Generation Contraceptives Market

The online channels segment is driving growth in the market for several compelling reasons. Primarily, online pharmacies offer unmatched convenience by enabling customers to order medications from their homes, a feature especially valued during the COVID-19 pandemic with its emphasis on social distancing. Furthermore, these platforms enhance accessibility by serving remote and underserved areas, providing a wide array of medications and healthcare services. Cost-effectiveness is another advantage, as online pharmacies often offer competitive pricing and discounts. Lastly, they improve customer experience through personalized services like online consultations, medication reminders, and seamless reordering processes, thereby revolutionizing how pharmaceuticals are accessed and managed.

The Female is Growing at the Highest Rate in the Next-Generation Contraceptives Market.

The female segment in the next-generation contraceptives market is experiencing robust growth driven by several pivotal factors. Increasing awareness and adoption of birth control methods among women are prompting a shift towards more effective and convenient options for managing reproductive health. Next-generation contraceptives, such as hormonal implants, intrauterine devices (IUDs), and injectable contraceptives, offer women enhanced convenience and affordability compared to traditional methods. There is a rising preference for Long-Acting Reversible Contraceptives (LARCs) like hormonal implants and IUDs due to their high effectiveness and long-term duration, reflecting a broader trend towards sustainable birth control solutions. Additionally, the popularity of injectable contraceptives is on the rise due to their ease of use and reliability, contributing to the overall expansion of the female market segment within the next-generation contraceptives landscape.

Regionally, North America Led the Next-Generation Contraceptives Market.

North America leads the Next-Generation Contraceptives Market due to several pivotal factors. The region boasts a high adoption rate of digital health technologies, such as mobile apps and online platforms, which facilitate the growth of innovative contraceptive solutions. Its robust healthcare infrastructure ensures widespread access to reproductive health services, supporting a strong demand for effective and convenient birth control methods. Increasing awareness of reproductive health and the importance of contraception further drives market expansion. Government support through funding for research, development, and regulatory approvals also bolsters the market landscape. Moreover, the region's high disposable income enables consumers to afford next-generation contraceptives, which often offer advanced features compared to traditional options.

Next-Generation Contraceptives Market Report Scope

Report Attribute

Specifications

Growth Rate CAGR

CAGR of 8.2% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Gender, By End User, By Offering and By Region

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia

Competitive Landscape

AbbVie, Bayer Corporation, Cooper Surgical, Inc., Church & Dwight Co, Inc., Merck & Co Inc., Pfizer, Reckitt Benckiser Group Plc, Teva Pharmaceuticals Industries Ltd., The Female Health Company/Veru Inc., Afaxys, Inc, Aditxt, Daré Bioscience, Inc, TherapeuticsMD Inc           

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape.                     

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Next-Generation Contraceptives Market Snapshot

Chapter 4. Global Next-Generation Contraceptives Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Gender Estimates & Trend Analysis

5.1. by Gender & Market Share, 2019 & 2031

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Gender:

5.2.1. Male

5.2.2. Female

Chapter 6. Market Segmentation 2: by End User Estimates & Trend Analysis

6.1. by End User & Market Share, 2019 & 2031

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:

6.2.1. Hospital Pharmacies

6.2.2. Retail Pharmacies

6.2.3. Online Channels

6.2.4. Others

Chapter 7. Market Segmentation 3: by Offering Estimates & Trend Analysis

7.1. by Offering & Market Share, 2019 & 2031

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Offering:

7.2.1. Drugs

7.2.2. Devices

Chapter 8. Next-Generation Contraceptives Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031

8.1.2. North America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031

8.1.3. North America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031

8.1.4. North America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

8.2. Europe

8.2.1. Europe Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031

8.2.2. Europe Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031

8.2.3. Europe Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031

8.2.4. Europe Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031

8.3.2. Asia Pacific Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031

8.3.3. Asia-Pacific Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031

8.3.4. Asia Pacific Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

8.4. Latin America

8.4.1. Latin America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031

8.4.2. Latin America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031

8.4.3. Latin America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031

8.4.4. Latin America Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2023-2031

8.5.2. Middle East & Africa Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by End User, 2023-2031

8.5.3. Middle East & Africa Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by Offering, 2023-2031

8.5.4. Middle East & Africa Next-Generation Contraceptives Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. AbbVie

9.2.2. Bayer Corporation

9.2.3. Cooper Surgical, Inc.

9.2.4. Church & Dwight Co, Inc.

9.2.5. Merck & Co Inc.

9.2.6. Pfizer

9.2.7. Reckitt Benckiser Group Plc

9.2.8. Teva Pharmaceuticals Industries Ltd.

9.2.9. The Female Health Company/Veru Inc.

9.2.10. Afaxys, Inc

9.2.11. Aditxt  

9.2.12. Daré Bioscience, Inc              

9.2.13. TherapeuticsMD, Inc          

9.2.14. Other Prominent Players

Segmentation of Next-Generation Contraceptives Market -

Next-Generation Contraceptives Market by Gender -

  • Male
  • Female

Next-Generation Contraceptives Market seg

Next-Generation Contraceptives Market by End User        -         

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channels
  • Others

 Next-Generation Contraceptives Market by Offering -

  • Drugs
  • Devices                                 

Next-Generation Contraceptives Market by Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

What is the Next-Generation Contraceptives Market Growth?

Pfizer, Reckitt Benckiser Group Plc, Teva Pharmaceuticals Industries Ltd., The Female Health Company/Veru Inc., Afaxys, Inc, Aditxt, Daré Bioscience,

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach